Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities – especially using QIAcuity digital PCR Tracer Biotechnologies partnership to develop blood-based minimal residual disease (MRD) tests on QIAcuity digital PCR systems for solid cancer tumors Collaboration with Foresight Diagnostics aims to develop a kit version of […]

Organization’s 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worldwide NEW YORK and MENLO PARK, Calif. — Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate long read sequencing platforms, to launch the largest global […]

Vancouver, British Columbia and Cambridge, United Kingdom – STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and […]

FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer. FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM Biotechnologies, serving global partners seeking CDMO services from preclinical to commercialization across a range of scales for biologics, advanced therapies and vaccines. Enhanced […]

CAMBRIDGE, UK – Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast board includes one investor director each from Arch Ventures, Illumina Ventures, M-Ventures, and Longwall Ventures; two independent directors, Kevin Knopp, CEO of 908 […]

The Medical Research Council Unit in The Gambia at the London School of Hygiene & Tropical Medicine and Oxford Nanopore are today celebrating the launch of their next generation nanopore Genomic Centre of Excellence Oxford Nanopore Technologies, the global company behind a new generation of nanopore-based molecular sensing technology and MRC Unit The Gambia (MRCG) […]

CAMBRIDGE, Mass. — Vizgen, Inc., a life sciences company advancing spatial multi-omics, today announced a strategic partnership with Hamamatsu Photonics K.K., a global leader in optical imaging technology. This collaboration integrates Hamamatsu’s MoxiePlex™ multiplex immunofluorescence (mIF) imaging system with Vizgen’s pathology-grade reagent and assay portfolio, delivering a seamless end-to-end solution designed to bring multiplexed biomarker detection […]

Improved Sample Throughput, Automation Capabilities and Updated Hardware Design FREMONT, Calif. — In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the launch of the Cytek Aurora™ Evo system, a new full spectrum flow cytometer that improves on its flagship Cytek Aurora system. First […]

Researchers can obtain deeper insights from cells with more colors and faster time to results with minimal sample volume WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed […]

REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument—its most advanced solution yet for scalable, high-resolution, mass spec-based proteomics. Seer’s newest innovation, debuting at the upcoming American Society for […]